Myomo Inc. (NYSE AMERICAN: MYO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MYOMO INC.

Myomo Inc. (NYSE AMERICAN: MYO)
Listen to this Section


$1.27
-0.0200 ( -1.55% ) 26.7K

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Market Data


Open $1.27
Previous Close $1.29
Volume 26.7K
Market Cap $42.50M
Day Range $1.28 - $1.33
52 Week Range $0.61 - $3.08
Shares Outstanding 38.64M
Change % -1.55%
Net Change ▼ -0.0200
Insider Ownership 0.00%
Exchange NYSE AMERICAN
SectorHealthcare
IndustryIndustrial Specialties
IPO Year2017
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -21,881.00

Date Type Amount Purchased Purchaser
2023-11-06 Sale -121.00 Kovelman Harry
2023-10-03 Sale -123.00 Kovelman Harry
2023-09-11 Buy 15000.00 Morris Milton Mayo
2023-09-06 Sale -125.00 Kovelman Harry
2023-08-31 Buy 48400.00 GUDONIS PAUL R
2023-08-30 Buy 8333.00 Kovelman Harry
2023-08-30 Buy 41666.00 HENRY DAVID A
2023-08-30 Buy 42500.00 GUDONIS PAUL R

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 64 Nov 10, 2025
8-k 8K-related 17 Nov 10, 2025
4 Insider transactions 1 Sep 11, 2025
4 Insider transactions 1 Aug 26, 2025
4 Insider transactions 1 Aug 19, 2025
4 Insider transactions 1 Aug 18, 2025
8-k 8K-related 12 Aug 11, 2025
10-q Quarterly Reports 63 Aug 11, 2025
4 Insider transactions 1 Jul 02, 2025
4 Insider transactions 1 Jul 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy